Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business ...
Completed Successful VAX-31 Phase 2 Adult Program; Company Remains on Track to Initiate VAX-31 Adult Phase 3 Pivotal, ...